Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified peptides and their use for treating autoimmune diseases

Modified peptides and their use for treating autoimmune diseases

US Patent 9657072 · Granted May 23, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide-oligourea hybrid compounds2022
Peptide-oligourea foldamer compounds and methods of their use2022
Pyrimidinone derivatives and uses thereof to neutralize the biological activity 2021
Pro-drug peptide with improved pharmaceutical properties2021
Peptide-oligourea chimeric compounds and methods of their use2019
Methods of treating chronic inflammatory diseases2019
Methods of treating chronic inflammatory diseases2019
Methods of treating chronic inflammatory diseases2019
Compositions comprising multivalent synthetic ligands of surface nucleolin and g2016
Nanoparticles containing a peptide, vectors containing said nanoparticles, and p2016
Use of multivalent synthetic ligands of surface nucleolin for treating cancer or2016
Optically pure compounds for improved therapeutic efficiency2016